HomeBIIB • NASDAQ
Biogen Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.43B | 6.13% |
Operating expense | 1.17B | 0.97% |
Net income | 240.50M | -38.87% |
Net profit margin | 9.89 | -42.43% |
Earnings per share | 3.02 | -17.71% |
EBITDA | 865.10M | 10.92% |
Effective tax rate | 22.72% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.60B | 141.84% |
Total assets | 28.03B | 5.52% |
Total liabilities | 11.05B | -2.64% |
Total equity | 16.98B | — |
Shares outstanding | 146.53M | — |
Price to book | 1.01 | — |
Return on assets | 6.08% | — |
Return on capital | 7.25% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 240.50M | -38.87% |
Cash from operations | 259.30M | -53.13% |
Cash from investing | -47.30M | 28.33% |
Cash from financing | -23.00M | 94.77% |
Net change in cash | 223.30M | 811.43% |
Free cash flow | 514.39M | 45.68% |
Previous close
$116.82
Day range
$116.22 - $118.00
Year range
$110.04 - $237.98
Market cap
17.16B USD
Avg Volume
1.73M
P/E ratio
11.56
Dividend yield
-
Primary exchange
NASDAQ
About
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Poland, Sweden, and Switzerland. Wikipedia
Founded
1978
Headquarters
Website
Employees
7,605
